Future research should continue to explore the various forms of ANGPTL4 and their specific roles in nephropathy, with a particular focus on the clinical potential of sialic acid precursors and recombinant mutant ANGPTL4 as therapeutic strategies for nephrotic syndrome. This evidence concerns the gene ANGPTL4 and kidney disorder.